Halozyme Therapeutics, Inc.HALONASDAQ
Loading
Income Tax Expense Over TimeExpanding
Percentile Rank100
3Y CAGR+47.4%
5Y CAGR+269.8%
Studio
Year-over-Year Change

Income taxes paid or accrued

3Y CAGR
+47.4%/yr
vs +205.5%/yr prior
5Y CAGR
+269.8%/yr
Recent deceleration
Acceleration
-158.1pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
691.2x
Strong expansion
Streak
4 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$149.99M+32.7%
2024$113.04M+69.4%
2023$66.73M+42.6%
2022$46.79M+130.3%
2021$-154.19M-71156.2%
2020$217000.00+2072.7%
2019$-11000.00-102.0%
2018$537000.00+139.5%
2017$-1.36M-217.1%
2016$1.16M-